Clinical Trial Details

Overview

Research Study Summary

A Phase 3, Multi-site, randomized, mixed-blind, parallel-group treatment withdrawl and re-treatment study of the efficacy and safety of 2 oral doses of CP-690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis

Purpose

Patient Inclusion Criteria:

  • 18+ years of age
  • Diagnosis of stable plaque psoriasis
  • Moderate to severe
  • Covering at least 10% of total body surface area

Patient Exclusion Criteria:

  • Currently have non-plaque forms of psoriasis, eg, erythrodermic, guttate, or pustular psoriasis

To Learn more

CW ID: 169613
Date Last Changed: July 23, 2013

Clinical Trial Snapshot

Phase
3
Gender
Both Male and Female
Age
18 and up
Overall Status
Recruiting
Facility Type
N/A

Contact

Dermatology Specialists, Inc.
3629 Vista Way
Oceanside, CA 92056
Phone: 760-757-7546

View Map

Research Center Information: Dermatology Specialists, Inc.

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.